Socioeconomic differences in antibiotic use for common infections in pediatric urgent-care centers-A quasi-experimental study

Infect Control Hosp Epidemiol. 2023 Dec;44(12):2009-2016. doi: 10.1017/ice.2023.107. Epub 2023 Jun 29.

Abstract

Objective: To investigate differences in the rate of firstline antibiotic prescribing for common pediatric infections in relation to different socioeconomic statuses and the impact of an antimicrobial stewardship program (ASP) in pediatric urgent-care clinics (PUCs).

Design: Quasi-experimental.

Setting: Three PUCs within a Midwestern pediatric academic center.

Patients and participants: Patients aged >60 days and <18 years with acute otitis media, group A streptococcal pharyngitis, community-acquired pneumonia, urinary tract infection, or skin and soft-tissue infections who received systemic antibiotics between July 2017 and December 2020. We excluded patients who were transferred, admitted, or had a concomitant diagnosis requiring systemic antibiotics.

Intervention: We used national guidelines to determine the appropriateness of antibiotic choice in 2 periods: prior to (July 2017-July 2018) and following ASP implementation (August 2018-December 2020). We used multivariable regression analysis to determine the odds ratios of appropriate firstline agent by age, sex, race and ethnicity, language, and insurance type.

Results: The study included 34,603 encounters. Prior to ASP implementation in August 2018, female patients, Black non-Hispanic children, those >2 years of age, and those who self-paid had higher odds of receiving recommended firstline antibiotics for all diagnoses compared to male patients, children of other races and ethnicities, other ages, and other insurance types, respectively. Although improvements in prescribing occurred after implementation of our ASP, the difference within the socioeconomic subsets persisted.

Conclusions: We observed socioeconomic differences in firstline antibiotic prescribing for common pediatric infections in the PUCs setting despite implementation of an ASP. Antimicrobial stewardship leaders should consider drivers of these differences when developing improvement initiatives.

MeSH terms

  • Ambulatory Care Facilities
  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Female
  • Humans
  • Male
  • Pharyngitis* / drug therapy
  • Practice Patterns, Physicians'
  • Respiratory Tract Infections* / drug therapy
  • Socioeconomic Factors
  • Urinary Tract Infections* / drug therapy

Substances

  • Anti-Bacterial Agents